Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

NCT00361283 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Atorvastatin

Sponsor

University of Florida

Collaborators

[object Object]
[object Object]